VectorBuilder is a multinational CDMO specializing in gene delivery and mRNA therapeutics. With headquarters in Chicago, Illinois, and additional offices in China, Germany, Japan, South Korea, Australia, and Israel, the company provides end-to-end solutions from preclinical research to commercial manufacturing, including plasmid and viral vector production, IVT mRNA synthesis, LNP formulation, process and analytical development, GMP manufacturing, aseptic fill/finish, and tech transfer. VectorBuilder supports clients globally with integrated gene therapy and mRNA development and manufacturing capabilities.